Semler Scientific faces shareholder class action over alleged False Claims Act violations.

A shareholder class action lawsuit has been filed against Semler Scientific, alleging that the company made false and misleading statements about a US Department of Justice investigation into possible violations of the False Claims Act. The lawsuit claims that the company's public statements were misleading, resulting in significant losses for investors who purchased shares between March 2021 and April 2025.

A shareholder class action lawsuit has been filed against Semler Scientific, alleging that the company made false and misleading statements about a U.S. Department of Justice (DOJ) investigation into possible violations of the False Claims Act. The lawsuit, filed on August 29, 2025, in the Northern District of California (Case No. 5:25-cv-07303), claims that Semler Scientific's public statements were misleading, resulting in significant losses for investors who purchased shares between March 2021 and April 2025 [1].

The lawsuit was initiated by shareholders who allege that Semler Scientific concealed a multi-year DOJ investigation into False Claims Act violations. On February 28, 2025, Semler Scientific disclosed settlement talks with the DOJ regarding these violations, causing its stock to drop by 9.38%. Subsequently, on April 15, 2025, the company announced an agreement in principle to settle for $29.75 million, leading to a further drop of 9.88% in share price [1].

Investors who purchased shares during the specified period are encouraged to monitor the lawsuit for potential recovery opportunities. As of now, over 600 companies are facing securities class action lawsuits, with more than 100 already paying settlements. Investors can connect their brokerage accounts to automatically check for missed lawsuits and potential recovery options [1].

References:
[1] https://www.tradingview.com/news/11thestate:6801915b0094b:0-shareholders-filed-a-lawsuit-against-semler-scientific-for-concealing-doj-investigation/